August 29, 2015 – This may after all not be so good news for Type 2-Diabetes patients on DPP-4 inhibitor medications. The American Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines containing the pharmacologically active …

Drug Safety Communication: DPP-4 inhibitors for Type 2-Diabetes may cause severe joint pain Read more »